AGP
LLY icon

Aspire Growth Partners’s Eli Lilly LLY Stock Holding History

Aspire Growth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
1,226
+155
+14% +$158K 0.85% 24
2026
Q1 		$985K Buy
1,071
+2
+0.2% +$2.03K 0.68% 34
2025
Q4 		$1.15M Sell
1,069
-98
-8% -$93.7K 0.8% 23
2025
Q3 		$891K Buy
1,167
+9
+0.8% +$6.7K 0.65% 34
2025
Q2 		$903K Sell
1,158
-54
-4% -$42K 0.74% 32
2025
Q1 		$941K Buy
1,212
+58
+5% +$48.3K 0.84% 32
2024
Q4 		$891K Buy
+1,154
New +$956K 0.87% 33

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspire Growth Partners's LLY Position: Q2 2026 in Review

Aspire Growth Partners increased its Eli Lilly (LLY) stake by 14% in Q2 2026, buying an estimated $158K and bringing the position to 1,226 shares worth $1.47M. The position accounts for 0.85% of the portfolio, ranked #24.

Aspire Growth Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aspire Growth Partners held 1,226 shares of Eli Lilly worth $1.47M as of Q2 2026.
  • Aspire Growth Partners bought 155 Eli Lilly shares in Q2 2026, an estimated $158K.
  • Eli Lilly made up 0.85% of Aspire Growth Partners's portfolio in Q2 2026, its #24 holding.
  • Aspire Growth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.